Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies



Hobson, James ORCID: 0000-0003-2551-1774, Al-Khouja, Amer, Curley, Paul ORCID: 0000-0003-4596-2708, Meyers, David, Flexner, Charles, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651, Freel Meyers, Caren and Rannard, SP ORCID: 0000-0002-6946-1097
(2019) Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies. Nature Communications, 10.

[img] Text
RANNARD SSPN NATURE COMM MAIN MANUSCRIPT ACCEPTED.docx - Author Accepted Manuscript

Download (3MB)
[img] Text
RANNARD SSPN NATURE COMM ESI.docx - Author Accepted Manuscript

Download (4MB)

Abstract

The increasing global prevalence of human immunodeficiency virus (HIV) is estimated at 36.7 million people currently infected. Lifelong antiretroviral (ARV) drug combination dosing allows management as a chronic condition by suppressing circulating viral load to allow for a near-normal life; however, the daily burden of oral administration may lead to non-adherence and drug resistance development. Long-acting (LA) depot injections of nanomilled poorly water-soluble ARVs have shown highly promising clinical results with drug exposure largely maintained over months after a single injection. ARV oral combinations rely on water-soluble backbone drugs which are not compatible with nanomilling. Here, we evaluate a unique prodrug/nanoparticle formation strategy to facilitate semi-solid prodrug nanoparticles (SSPNs) of the highly water-soluble nucleoside reverse transcriptase inhibitor (NRTI) emtricitabine (FTC), and injectable aqueous nanodispersions; in vitro to in vivo extrapolation (IVIVE) modelling predicts sustained prodrug release, with activation in relevant biological environments, representing a first step towards complete injectable LA regimens containing NRTIs.

Item Type: Article
Uncontrolled Keywords: Diseases, Drug delivery, Drug discovery, Infectious diseases, Pharmacology
Depositing User: Symplectic Admin
Date Deposited: 12 Mar 2019 09:34
Last Modified: 19 Jan 2023 00:57
DOI: 10.1038/s41467-019-09354-z
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3034105